NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-233-2014-0-NO-18 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation NO EP 14796317.7 Issued
NCI E-233-2014-0-FR-14 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation FR EP 14796317.7 Issued
NCI E-233-2014-0-DK-13 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation DK EP 14796317.7 Issued
NCI E-233-2014-0-BE-12 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation BE EP 14796317.7 Issued
NCI E-233-2014-0-SE-20 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation SE EP 14796317.7 Issued
NCI E-233-2014-0-ES-19 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation ES EP 14796317.7 Issued
NCI E-233-2014-0-CH-21 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation CH EP 14796317.7 Issued
NCI E-233-2014-0-IT-16 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation IT EP 14796317.7 Issued
CC E-170-2012-0-US-06 LARGE VOLUME, CONFORMAL HYPERTHERMIA WITH MAGNETIC RESONANCE-GUIDED HIGH INTENSITY FOCUSED ULTRASOUND US National Stage 14/390,181 11116405 Issued PDF
NCI E-229-2014-0-AU-02 Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation AU National Stage 2014407540 Issued
NCI E-229-2014-0-US-07 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION US National Stage 15/515,055 10973894 Issued PDF
NCI E-233-2014-0-AU-02 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation AU National Stage 2014407539 Issued
NCI E-233-2014-0-JP-06 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation JP National Stage 2017-517662 Issued
NCI E-229-2014-0-JP-06 Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation JP National Stage 2017-517677 Issued
NCI E-086-2012-2-US-05 Methods For Generation Of Pluripotent And Multipotent Cells US National Stage 14/390,134 10407665 Issued PDF
NICHD E-084-2012-0-US-04 Polarmetric Accessory For Colposcope US National Stage 14/390,354 9801536 Issued PDF
NCI E-229-2014-0-PCT-01 Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation PCT PCT PCT/US2014/058805 Expired
NCI E-233-2014-0-PCT-01 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation PCT PCT PCT/US2014/058796 Expired
NCI E-229-2014-0-CN-04 Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation CN National Stage 201480082922.X Abandoned
NCI E-233-2014-0-CN-04 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation CN National Stage 201480082932.3 Abandoned
NCI E-229-2014-0-EP-05 Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation EP National Stage 14790878.4 Abandoned
NCI E-771-2013-4-VE-07 Modified Pseudomonas Exotoxin A VE ORD 1162-14 Abandoned
NCI E-229-2014-0-CA-03 Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation CA National Stage 2963364 Pending
NHLBI E-342-2013-0-DE-09 Human IPSC-Derived Vascular-Related And Hematopoetic Cells For Therapies And Toxicology/Drug Screenings DE EP 14790863.6 Issued
NHLBI E-342-2013-0-IE-12 Human IPSC-Derived Vascular-Related And Hematopoetic Cells For Therapies And Toxicology/Drug Screenings IE EP 14790863.6 Issued
NHLBI E-342-2013-0-FR-10 Human IPSC-Derived Vascular-Related And Hematopoetic Cells For Therapies And Toxicology/Drug Screenings FR EP 14790863.6 Issued
NHLBI E-342-2013-0-CH-08 Human IPSC-Derived Vascular-Related And Hematopoetic Cells For Therapies And Toxicology/Drug Screenings CH EP 14790863.6 Issued
NHLBI E-342-2013-0-GB-11 Human IPSC-Derived Vascular-Related And Hematopoetic Cells For Therapies And Toxicology/Drug Screenings GB EP 14790863.6 Issued
NHLBI E-342-2013-0-EP-04 Human IPSC-Derived Vascular-Related And Hematopoetic Cells For Therapies And Toxicology/Drug Screenings EP National Stage 14790863.6 Issued
NIDCR E-619-2013-0-EP-04 00METHODS OF MODULATING ERYTHROPOIESIS WITH ARGININE VASOPRESSIN RECEPTOR 1B MOLECULES EP National Stage 14790866.9 Abandoned
NIDCR E-619-2013-0-GB-07 00METHODS OF MODULATING ERYTHROPOIESIS WITH ARGININE VASOPRESSIN RECEPTOR 1B MOLECULES GB EP 14790866.9 Abandoned
NIDCR E-619-2013-0-FR-06 00METHODS OF MODULATING ERYTHROPOIESIS WITH ARGININE VASOPRESSIN RECEPTOR 1B MOLECULES FR EP 14790866.9 Abandoned
NIDCR E-619-2013-0-DE-05 00METHODS OF MODULATING ERYTHROPOIESIS WITH ARGININE VASOPRESSIN RECEPTOR 1B MOLECULES DE EP 14790866.9 Abandoned
NIAID E-019-2007-2-KR-18 Vaccines Against Potential Pandemic Strains Of Influenza KR DIV 10-2014-7031694 Abandoned
NHLBI E-342-2013-0-PCT-02 Human IPSC-derived Vascular-Related And Hematopoetic Cells For Therapies And Toxicology/Drug Screenings PCT PCT PCT/US2014/058583 Expired
NCATS E-018-2015-0-US-01 2-substituted Pyridines And Their Methods For Inhibiting BMP Signaling US 62/058,377 Abandoned
NHGRI E-081-2014-0-US-01 METHODS OF TREATING PXE WITH TNAP INHIBITORS US 62/058,505 Abandoned
NHLBI E-342-2013-0-CA-05 Human IPSC-derived Vascular-Related And Hematopoetic Cells For Therapies And Toxicology/Drug Screenings CA National Stage 2925774 Pending
NCI E-040-2012-0-US-22 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US National Stage 14/389,677 9765342 Issued PDF
NINDS E-023-2014-0-PCT-02 Insulin-Like Growth Factor Mimetics For Use In Therapy PCT PCT PCT/IB2014/064952 Expired
NINDS E-023-2014-0-JP-10 Insulin-Like Growth Factor Mimetics For Use In Therapy JP National Stage 2016-546190 Abandoned
NINDS E-023-2014-0-CA-05 Insulin-Like Growth Factor Mimetics For Use In Therapy CA National Stage 2926173 Abandoned
NINDS E-023-2014-0-KR-11 Insulin-Like Growth Factor Mimetics For Use In Therapy KR National Stage 10-2016-7011097 Abandoned
NINDS E-023-2014-0-MX-12 Insulin-Like Growth Factor Mimetics For Use In Therapy MX National Stage MX/a/2016/004261 Abandoned
NINDS E-023-2014-0-AU-03 Insulin-Like Growth Factor Mimetics For Use In Therapy AU National Stage 2014330853 Abandoned
NINDS E-023-2014-0-IN-09 Insulin-Like Growth Factor Mimetics For Use In Therapy IN National Stage 201617005586 Abandoned
NINDS E-023-2014-0-EA-07 Insulin-Like Growth Factor Mimetics For Use In Therapy EA National Stage 201690490 Abandoned
NCI E-040-2012-0-IL-12 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen IL National Stage 234870 Issued
NCI E-227-2006-5-US-10 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS US DIV 14/500,861 10370439 Issued PDF
NICHD E-239-2012-0-US-04 A METHOD FOR LATE POST COITAL CONTRACEPTION US CON 14/499,991 Abandoned